Seres Therapeutics Inc’s recently made public that its Chief Legal Officer and EVP DesRosier Thomas unloaded Company’s shares for reported $475.0 on Nov 18 ’24. In the deal valued at $0.54 per share,878 shares were sold. As a result of this transaction, DesRosier Thomas now holds 135,192 shares worth roughly $0.1 million.
Then, von Moltke Lisa sold 977 shares, generating $528 in total proceeds. Upon selling the shares at $0.54, the insider now owns 32,415 shares.
Before that, Shaff Eric D. sold 2,505 shares. Seres Therapeutics Inc shares valued at $1,355 were divested by the CEO and President at a price of $0.54 per share. As a result of the transaction, Shaff Eric D. now holds 170,389 shares, worth roughly $0.13 million.
JP Morgan downgraded its Seres Therapeutics Inc [MCRB] rating to an Underweight from a a Neutral in a research note published recently. JP Morgan began covering MCRB with “Neutral” recommendation on April 21, 2023. Goldman revised its rating on July 23, 2021. It rated MCRB as “a Sell” which previously was an “a Neutral”.
Price Performance Review of MCRB
On Tuesday, Seres Therapeutics Inc [NASDAQ:MCRB] saw its stock fall -6.90% to $0.77. Over the last five days, the stock has lost -15.48%. Seres Therapeutics Inc shares have fallen nearly -7.79% since the year began. Nevertheless, the stocks have fallen -34.50% over the past one year. While a 52-week high of $1.53 was reached on 01/06/25, a 52-week low of $0.54 was recorded on 01/14/25. SMA at 50 days reached $0.8227, while 200 days put it at $0.8852.
Levels Of Support And Resistance For MCRB Stock
The 24-hour chart illustrates a support level at 0.7353, which if violated will result in even more drops to 0.7044. On the upside, there is a resistance level at 0.8119. A further resistance level may holdings at 0.8576. The Relative Strength Index (RSI) on the 14-day chart is 38.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0607, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.48%. Stochastics %K at 12.97% indicates the stock is a buying.
How much short interest is there in Seres Therapeutics Inc?
A steep rise in short interest was recorded in Seres Therapeutics Inc stocks on 2024-12-31, growing by 3.06 million shares to a total of 20.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 17.38 million shares. There was a rise of 14.96%, which implies that there is a positive sentiment for the stock.
